Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4nm0 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 4nm0 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 1.000 | |
| 4nm7 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.714 | |
| 4b7t | CWT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.628 | |
| 4nm5 | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.628 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.554 | |
| 4acd | GR9 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.521 | |
| 3q3b | 55E | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.520 | |
| 4acc | 7YG | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.520 | |
| 1pyx | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.511 | |
| 3zrm | ZRM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.508 | |
| 3du8 | 553 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.503 | |
| 4j1r | I5R | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.500 | |
| 3sd0 | TSK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.497 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.496 | |
| 3zrl | ZRL | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.495 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.495 | |
| 1u5r | ATP | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.490 | |
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.490 | |
| 3l1s | Z92 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.489 | |
| 3zrk | ZRK | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.487 | |
| 4ach | KDI | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.486 | |
| 4afj | SJJ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.486 | |
| 4acg | 6LQ | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.485 | |
| 3say | OFT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.484 | |
| 3gb2 | G3B | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.480 | |
| 4j71 | 1JX | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.479 | |
| 1j1b | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.475 | |
| 1gy3 | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.473 | |
| 4gvj | ADP | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.470 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.469 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.464 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.464 | |
| 3f88 | 3HT | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.463 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.463 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.463 | |
| 3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.462 | |
| 2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.460 | |
| 4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.460 | |
| 4jrn | ANP | Rhoptry kinase family protein | / | 0.459 | |
| 1hk3 | T44 | Serum albumin | / | 0.458 | |
| 2cch | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.456 | |
| 4dfn | 0K1 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.455 | |
| 4fl2 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.455 | |
| 1q4l | 679 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.454 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.453 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.453 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.452 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.451 | |
| 3ori | AGS | Serine/threonine protein kinase | / | 0.451 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.450 | |
| 1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.450 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.450 | |
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.450 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.449 | |
| 2pml | ANP | Uncharacterized protein | / | 0.449 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.448 | |
| 1lp4 | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.447 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.447 | |
| 2ow3 | BIM | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.446 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.446 | |
| 4y12 | AGS | Serine/threonine-protein kinase PknG | 2.7.11.1 | 0.446 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.445 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.445 | |
| 2bxn | IDB | Serum albumin | / | 0.444 | |
| 2wms | ZYS | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 4bgg | 844 | Activin receptor type-1 | 2.7.11.30 | 0.444 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.443 | |
| 2z7q | ACP | Ribosomal protein S6 kinase alpha-1 | 2.7.11.1 | 0.443 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 2bxi | AZQ | Serum albumin | / | 0.442 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.442 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.442 | |
| 3wow | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.442 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 1q3d | STU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.440 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.440 |